TOPICS TO READ
EMPAREG: Jardiance reduces MI, CVA, death in patients with vascular disease [SGLT-2 inhibitor]
LEADER: Victoza reduces MI, CVA, death in patients with vascular disease [GLP-1 agonist]
EMPAREG: Jardiance reduces MI, CVA, death in patients with vascular disease [SGLT-2 inhibitor]
LEADER: Victoza reduces MI, CVA, death in patients with vascular disease [GLP-1 agonist]